Gucon, Geberlyn .
HRN: 22-16-12 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CO-AMOXICLAV 625MG (TAB)
12/28/2022
01/05/2023
PO
625mg
Bid
Thickly Msaf
Waiting Final Action